Evidence map›Paper›PMID 33085029›Full record

ReviewJapanese journal of radiology2020

CT and MRI of pancreatic tumors: an update in the era of radiomics.

Marion Bartoli, Maxime Barat, Anthony Dohan, Sébastien Gaujoux, Romain Coriat, Christine Hoeffel, Christophe Cassinotto, Guillaume Chassagnon, Philippe Soyer

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Japanese journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07243288 (Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07243288 active not recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2024 to 2026Enrolled400ConditionsPancreatic Cancer, MeSH Term-Pancreatic Cancer, Adult)ArmsPatients treated with FOLFOX or FOLFIRINOX in first line, Patients treated with GEMCITABINE in first line
3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Catching pancreatic cancer early: Are we there yet?Journal of the National Cancer Center · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Landmarks in pancreatic cancer studies.Cancer cell international · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marion BartoliDepartment of Radiology, Cochin Hospital, AP-HP, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France.
Maxime BaratDepartment of Radiology, Cochin Hospital, AP-HP, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France.
Anthony DohanDepartment of Radiology, Cochin Hospital, AP-HP, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France.
Sébastien GaujouxUniversité de Paris, Descartes-Paris 5, F-75006, Paris, France.
Romain CoriatUniversité de Paris, Descartes-Paris 5, F-75006, Paris, France.
Christine HoeffelDepartment of Radiology, Robert Debré Hospital, 51092, Reims, France.
Christophe CassinottoDepartment of Radiology, CHU Montpellier, University of Montpellier, Saint-Éloi Hospital, 34000, Montpellier, France.
Guillaume ChassagnonDepartment of Radiology, Cochin Hospital, AP-HP, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France.
Philippe SoyerDepartment of Radiology, Cochin Hospital, AP-HP, 27 Rue du Faubourg Saint-Jacques, 75014, Paris, France. philippe.soyer@aphp.fr.ORCID http://orcid.org/0000-0002-5055-1682

Funding

Advanced Software for MRI, PET, SPECT and CT Image AnalysisU24EB028980 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RUSINEK, HENRY · 2019 to 2021
$1.2M
NIBIB NIH HHS U24 EB028980
6 · The paper itself

Abstract

Radiomics is a relatively new approach for image analysis. As a part of radiomics, texture analysis, which consists in extracting a great amount of quantitative data from original images, can be used to identify specific features that can help determining the actual nature of a pancreatic lesion and providing other information such as resectability, tumor grade, tumor response to neoadjuvant therapy or survival after surgery. In this review, the basic of radiomics, recent developments and the results of texture analysis using computed tomography and magnetic resonance imaging in the field of pancreatic tumors are presented. Future applications of radiomics, such as artificial intelligence, are discussed.

Indexed as

Magnetic Resonance ImagingTomography, X-Ray ComputedArtificial IntelligenceCarcinoma, Pancreatic DuctalDiagnosis, DifferentialHumansImage Processing, Computer-AssistedNeoplasm GradingNeuroendocrine TumorsPancreasPancreatic NeoplasmsPrognosisArtificial intelligencePancreatic neoplamsRadiomicsTexture analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.